2. Signaling Pathways
  3. Others
  4. Drug Intermediate

Drug Intermediate

Drug Iintermediate

Drug intermediates are used as raw materials for the production of bulk drugs, or they can refer to a material produced during synthesis of an API that must undergo further molecular change or processing before it becomes an API. Drug intermediates are hygienically formulated using high grade raw materials and they are used in the pharmaceutical and cosmetic industry[1][2].

Drug Intermediate Related Products (4393):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-Z0610
    7-Deazapurine impurity 1
    7-Deazapurine impurity 1 is a drug impurity.
    7-Deazapurine impurity 1
  • HY-I0278
    Tofacitinib impurity 32
    		99.53%
    Tofacitinib impurity 32 is an impurity of Tofacitinib (HY-40354).
    Tofacitinib impurity 32
  • HY-Y0211
    2-(4-Aminophenoxy)-2-methylpropanoic acid
    		98.08%
    2-(4-Aminophenoxy)-2-methylpropanoic acid is a drug intermediate for synthesis of various active compounds.
    2-(4-Aminophenoxy)-2-methylpropanoic acid
  • HY-I0198
    1-(4-Iodophenyl)-2-piperidinone
    		98.77%
    1-(4-Iodophenyl)-2-piperidinone (1-(4-Iodophenyl)piperidin-2-one) is a drug intermediate for synthesis of various active compounds.
    1-(4-Iodophenyl)-2-piperidinone
  • HY-79791
    2-Acetamidomalonate sodium
    		98.0%
    2-Acetamidomalonate sodium is a drug intermediate for synthesis of various active compounds.
    2-Acetamidomalonate sodium
  • HY-W882830
    (S)-3-(4-(4-((14-Azido-3,6,9,12-tetraoxatetradecyl)oxy)naphthalen-1-yl)phenyl)-3-(2-(4-((4-methylpyridin-2-yl)amino)butanamido)acetamido)propanoic acid compound trifluoroacetate
    		99.78%
    (S)-3-(4-(4-((14-Azido-3,6,9,12-tetraoxatetradecyl)oxy)naphthalen-1-yl)phenyl)-3-(2-(4-((4-methylpyridin-2-yl)amino)butanamido)acetamido)propanoic acid compound trifluoroacetate is a drug intermediate for synthesis of various active compounds.
    (S)-3-(4-(4-((14-Azido-3,6,9,12-tetraoxatetradecyl)oxy)naphthalen-1-yl)phenyl)-3-(2-(4-((4-methylpyridin-2-yl)amino)butanamido)acetamido)propanoic acid compound trifluoroacetate
  • HY-46459
    4-(4-Bromophenyl)piperidin-2-one
    		99.39%
    4-(4-Bromophenyl)piperidin-2-one is a drug intermediate for synthesis of various active compounds.
    4-(4-Bromophenyl)piperidin-2-one
  • HY-50806
    (1R,2R)-2-(4-Bromobenzoyl)cyclopentane-1-carboxylic acid
    		99.25%
    (1R,2R)-2-(4-Bromobenzoyl)cyclopentane-1-carboxylic acid is a drug intermediate for synthesis of various active compounds.
    (1R,2R)-2-(4-Bromobenzoyl)cyclopentane-1-carboxylic acid
  • HY-185060
    N-Acetyllactosamine-C2-NH2
    N-Acetyllactosamine-C2-NH2 (Compound β-D-Gal-(l-4)-β-D- GlcNAc-(l-4))-l-ethylamine) is a disaccharide compound and is the core backbone component for constructing sialylated glycans (sialosides) .
    N-Acetyllactosamine-C2-NH2
  • HY-20552
    Olmesartan impurity 13
    Olmesartan impurity 13 is an impurity of Olmesartan.
    Olmesartan impurity 13
  • HY-30440
    (S)-1-(4-(Trifluoromethoxy)phenyl)ethanamine
    		99.37%
    (S)-1-(4-(Trifluoromethoxy)phenyl)ethanamine is a drug intermediate for synthesis of various active compounds.
    (S)-1-(4-(Trifluoromethoxy)phenyl)ethanamine
  • HY-W002108
    3,4-Dihydroquinolin-2(1H)-one
    3,4-Dihydroquinolin-2(1H)-one is a building block, that can be used for synthesis of antipsychotic agent, such as Aripiprazole (HY-14546) or CYP11B2 inhibitors.
    3,4-Dihydroquinolin-2(1H)-one
  • HY-W008727
    Amodiaquine impurity 1
    		98.70%
    Amodiaquine impurity 1 is an impurity of Amodiaquine (HY-B1322A).
    Amodiaquine impurity 1
  • HY-W139907
    1,2-Dimethylbenzimidazole
    		98.0%
    1,2-Dimethylbenzimidazole is a benzimidazole derivative. 1,2-Dimethylbenzimidazole exhibits antiparasitic activity with an IC50 of 0.089 μM against G. duodenalis. 1,2-Dimethylbenzimidazole can also be used in the synthesis of other bioactive compounds, such as antitumor agents.
    1,2-Dimethylbenzimidazole
  • HY-129844
    Biphenyl-4-amidoxime
    		99.80%
    Biphenyl-4-amidoxime (N'-hydroxy-4-phenylbenzene-1-carboximidamide) is a synthetic intermediate useful for pharmaceutical synthesis.
    Biphenyl-4-amidoxime
  • HY-I0210S
    4-Iodoaniline-13C6
    		99.17%
    4-Iodoaniline-13C6 is the 13C labeled 4-Iodoaniline (HY-I0210). 4-Iodoaniline is a potent methemoglobin former. 4-Iodoaniline is also an intermediate. 4-Iodoaniline can be used to synthesize glycogen phosphorylase inhibitors. 4-Iodoaniline is used in the research of liver cancer and blood diseases.
    4-Iodoaniline-<sup>13</sup>C<sub>6</sub>
  • HY-W032995
    Methyl 3-carbamoylbicyclo[1.1.1]pentane-1-carboxylate
    Methyl 3-carbamoylbicyclo[1.1.1]pentane-1-carboxylate is a drug intermediate for synthesis of various active compounds.
    Methyl 3-carbamoylbicyclo[1.1.1]pentane-1-carboxylate
  • HY-W092495
    Methyl 3-(1H-indol-3-yl)propanoate
    Methyl 3-(1H-indol-3-yl)propanoate is an indole derivative and can be used as a drug intermediate.
    Methyl 3-(1H-indol-3-yl)propanoate
  • HY-W007410
    2,4-Difluorobenzaldehyde
    		99.88%
    2,4-Difluorobenzaldehyde is an organic chemical, that can be used in medicine, pesticide, liquid crystal materials intermediate.
    2,4-Difluorobenzaldehyde
  • HY-21997
    DMT-2'fluoro-da(bz) amidite
    		99.6%
    DMT-2'fluoro-da(bz) amidite is a key intermediate for synthesizing antisense oligonucleotides with high nuclease resistance, high RNA binding affinity, and maintained base-pair specificity.
    DMT-2'fluoro-da(bz) amidite